Sharp-Header

Sharp-Header

X

Find

Active Pharmaceutical Ingredients
Finished Drug Formulations
Prices
Excipients
Services
Marketplace

Market Place

Post Enquiry

Grow Your Pharma Business Digitally

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

All Data

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Reset Filter

All Drugs in Dev.

Product Type

Companies

Targovax

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

Food & Nutrition Conference & Expo

Participation Not Confirmed

Update your Virtual Booth

Targovax Grants IOVaxis 3 Months Extension to the Exclusive License Option for TG Mut...

Lead Product(s): TG01

Therapeutic Area: Oncology Product Name: TG01

Highest Development Status: IND Enabling Product Type: Vaccine

Partner/Sponsor/Collaborator: IOVaxis Therapeutics

Deal Size: $3.0 million Upfront Cash: Undisclosed

Deal Type: Licensing Agreement January 06, 2021